Patients with Parkinson disease exhibit a highly increased prevalence of small intestinal bacterial overgrowth (SIBO), which has been also associated with the severity of motor fluctuations. Aim of this study was to test the efficacy of liquid levodopa with higher bioavailability in patients with SIBO.

Fasano, A., Gabrielli, M., Ragazzoni, E., Tortora, A., Zocco, M. A., Marconi, S., Gasbarrini, A., Bentivoglio, A. R., Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth, <<CLINICAL NEUROPHARMACOLOGY>>, 2014; 37 (4): 91-95. [doi:10.1097/WNF.0000000000000034] [http://hdl.handle.net/10807/60732]

Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth

Gabrielli, Maurizio;Ragazzoni, Enzo;Tortora, Annalisa;Zocco, Maria Assunta;Gasbarrini, Antonio;Bentivoglio, Anna Rita
2014

Abstract

Patients with Parkinson disease exhibit a highly increased prevalence of small intestinal bacterial overgrowth (SIBO), which has been also associated with the severity of motor fluctuations. Aim of this study was to test the efficacy of liquid levodopa with higher bioavailability in patients with SIBO.
Inglese
Fasano, A., Gabrielli, M., Ragazzoni, E., Tortora, A., Zocco, M. A., Marconi, S., Gasbarrini, A., Bentivoglio, A. R., Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth, <<CLINICAL NEUROPHARMACOLOGY>>, 2014; 37 (4): 91-95. [doi:10.1097/WNF.0000000000000034] [http://hdl.handle.net/10807/60732]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/60732
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 14
social impact